Targeting responsive release system and preparation method and application thereof
A release system and responsive technology, applied in pharmaceutical formulations, organic active ingredients, non-central analgesics, etc., can solve the problems of other tissues and organs with side effects, poor treatment effect, infection, etc., to improve delivery efficiency and utilization rate, avoid off-target effects or leakage of active substances, and solve the effect of poor treatment effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Example Embodiment
[0068] Example 1 Targeted responsive release system loaded with MicroRNA-21
[0069] A targeted responsive release system is provided, the targeted responsive release system comprises a chimeric apoptotic body, the chimeric apoptotic body comprising an apoptotic body membrane and a membrane wrapped in the apoptotic body The mesoporous silica nanoparticles in, the apoptotic body membrane is an apoptotic body membrane derived from T cells, and the mesoporous silica nanoparticles are loaded with MicroRNA-21. In some embodiments, MicroRNA-21 is loaded on the mesoporous nanoparticles through electrostatic action. In some embodiments, MicroRNA-21 breaks the disulfide bond through glutathione in the cytoplasm of the target cell, resulting in the release of MicroRNA-21 into the target cell. In a preferred embodiment, the MicroRNA-21 is labeled with Cy5.
Example Embodiment
[0070] Example 2 Targeted responsive release system loaded with curcumin
[0071] A targeted responsive release system is provided, the targeted responsive release system comprises a chimeric apoptotic body, the chimeric apoptotic body comprising an apoptotic body membrane and a membrane wrapped in the apoptotic body The mesoporous silica nanoparticles in, the apoptotic body membrane is an apoptotic body membrane derived from T cells, and the mesoporous silica nanoparticles are loaded with curcumin.
[0072] In some embodiments, after the curcumin is loaded in the pores of the mesoporous silica nanoparticles by physical adsorption, the mesoporous silica nanoparticles are encapsulated with polyglycerol dimethacrylate.
[0073] In some embodiments, the curcumin degrades the polyglyceryl dimethacrylate by esterases in the target cells, thereby being released in the target cells in response.
Example Embodiment
[0074] Example 3: Preparation of apoptotic body membrane
[0075] 1. T cell isolation, activation and identification
[0076] Primary T cells were derived from C57BL / 6 mouse spleen cells and were cultured in RPMI-1640 medium containing 20% FBS and 1% penicillin / streptomycin. First, inoculate 2μg / ml CD3ε antibody in a 6-well plate and incubate at 37°C for 4 hours. Separate and take out the mouse spleen, grind the spleen thoroughly with a sterile syringe handle, filter to form a cell suspension, add sterile red blood cell lysis solution, gently pipet and mix well, lyse on ice for 10 minutes, perform cell centrifugation after lysis, and use medium again Resuspend the cells. Then filter the cell suspension with a 100μm filter to remove cell clumps, add 2μg / ml CD28 antibody, and then inoculate it into a 6-well plate pre-coated with CD3ε antibody. After culturing the T cells at 37°C and 5% CO2 for 24-72h After being activated, 1μg / ml lipopolysaccharide was added to the culture syste...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap